Which inborn errors of metabolism present during the weaning period with tachypnea and metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Inborn Errors of Metabolism Presenting During Weaning with Tachypnea and Acidosis

The classic organic acidemias—particularly propionic acidemia, methylmalonic acidemia, and isovaleric acidemia—are the primary inborn errors of metabolism that manifest during the weaning period with tachypnea and metabolic acidosis. 1

Key Disorders to Consider

The weaning period (typically 4-12 months when protein intake increases with introduction of solid foods) triggers metabolic decompensation in several specific IEMs:

Classic Organic Acidemias (Most Common)

  • Propionic acidemia - presents with ketolactic acidosis, hyperammonemia, and tachypnea as respiratory compensation 1
  • Methylmalonic acidemia - similar presentation with severe metabolic acidosis and compensatory tachypnea 1, 2
  • Isovaleric acidemia - characterized by metabolic acidosis with distinctive "sweaty feet" odor 1

Other Important Considerations

  • Maple syrup urine disease (MSUD) - presents with ketoacidosis during increased protein intake 1
  • Multiple acyl-CoA dehydrogenase deficiency (MADD) - fatty acid oxidation defect causing metabolic acidosis 1
  • Beta-ketothiolase deficiency - rare but presents with severe ketoacidosis and tachypnea 3

Clinical Recognition Pattern

The weaning period is a critical trigger because:

  • Increased dietary protein load from solid food introduction overwhelms deficient enzymatic pathways
  • Tachypnea represents respiratory compensation for metabolic acidosis (Kussmaul breathing)
  • Symptoms often include lethargy, poor feeding, vomiting, and recurrent episodes 4, 5

Diagnostic Approach

Immediate laboratory evaluation must include: 1, 5

  • Blood gas analysis (metabolic acidosis with elevated anion gap)
  • Plasma ammonia level (often elevated in organic acidemias)
  • Blood glucose (to distinguish from hypoglycemic disorders)
  • Urine organic acids by GC-MS (first-tier diagnostic test)
  • Plasma amino acids
  • Plasma acylcarnitine profile

Critical Pitfall

Do not assume sepsis is the sole diagnosis in an infant with acidosis and tachypnea during weaning—metabolic disorders should always be in the differential, particularly in full-term infants without specific infection risk factors 4, 5. The ACMG guidelines emphasize that organic acid analysis is crucial for any infant presenting with unexplained metabolic acidosis 1.

Distinguishing Features

Look for these specific clues:

  • Ketolactic acidosis with hyperammonemia suggests organic acidemias 1
  • Normal or low ketones with hypoglycemia suggests fatty acid oxidation defects 4, 5
  • Unusual odor (sweaty feet in isovaleric acidemia, maple syrup in MSUD) 1
  • Recurrent episodes triggered by increased protein intake or illness 4

The timing during weaning is particularly characteristic because the transition to higher protein solid foods unmasks these amino acid metabolism defects that may have been compensated during exclusive breast milk or formula feeding 4, 5.

Related Questions

What metabolic disorders should be considered in a 4‑month‑old infant with megacolon, recurrent hypoglycemia, transfusion‑dependent anemia, thrombocytopenia, acute renal failure on dialysis, and ongoing sepsis who has a normal chest X‑ray and no hepatosplenomegaly, and what initial management is recommended?
What is the differential diagnosis, including metabolic disorders, for an 8‑day‑old neonate with feeding difficulty, failure to gain weight, regurgitation, and intermittent non‑bilious vomiting without fever?
How should a newborn presenting with poor feeding, lethargy, vomiting, seizures, respiratory distress, hypotonia, hepatomegaly, metabolic acidosis, hypoglycemia, and hyperammonemia be evaluated and managed for a suspected inborn error of metabolism?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In an asymptomatic patient with chronic kidney disease, serum creatinine 2.0 mg/dL, arterial pH 7.19, serum bicarbonate 15 mEq/L, and normal vital signs, should oral sodium bicarbonate tablets with outpatient monitoring be started, or is intravenous sodium bicarbonate infusion indicated?
In an adult (≥18 years) with a well‑defined keloid and no uncontrolled diabetes, what is the recommended intralesional regular human insulin regimen for keloid flattening?
What is the significance of an elevated total leukocyte count of 12.5 × 10⁹/L with a decreased lymphocyte proportion on the differential?
What is the recommended management of acute crisis episodes in patients with organic acidemias?
For a patient undergoing a laminectomy, how many days before surgery should apixaban (Eliquis) 2.5 mg twice daily and fish‑oil supplements be stopped?
What is the recommended dosing of pimavanserin (Nuplazid), including dose adjustments for renal or hepatic impairment and CYP3A4 inhibitor or inducer use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.